Clinical Trials Logo

Clinical Trial Summary

This clinical trial is designed to learn more about treating patients with lower limb lymphoedema following gynaecological surgery. The main question to be answered is To evaluate the efficacy of Daphnetin capsule in the treatment of patients with lower limb lymphedema following gynaecological malignancy surgery. Participants will take Daphnetin capsule 150mg tid (3 capsules/time, 3 times daily) orally at the same time as gradient compression stocking treatment. Researchers will compare 150mg Forte tablets (2 capsules/time, 2 times daily) and gradient compression stockings to see if Daphnetin capsule can be used to treat patients with lower extremity lymphedema following gynaecological malignancy surgery.


Clinical Trial Description

This study was a randomised, controlled, open-label, single-centre clinical trial. The objective of this study was to determine the efficacy and safety of Daphnetic capsules compared to Aesculete tablets in the treatment of patients with lower extremity lymphedema following gynaecological cancer surgery. A total of 100 patients with postoperative lower extremity lymphedema (stage I-II) following gynaecological cancer surgery were enrolled in this randomised controlled trial. Patients were randomised 1:1 to the experimental or control group. Subjects who met the inclusion and exclusion criteria were randomly allocated to the Daphnetin group (study group) or the Aesculeum aesculeum group (control group) in a 1:1 ratio after signing the informed consent form. Both groups were treated for 21 days as a cycle, and efficacy and safety indices were evaluated after the first course of treatment. Group A: Daphnetin capsule 150mg tid (3 capsules/time, 3 times daily) and gradient compression stockings. Group B: Aescuven Forte oral tablet 150mg (2 capsules/time, 2 times daily) and gradient compression stockings. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06329167
Study type Interventional
Source The First Hospital of Jilin University
Contact
Status Recruiting
Phase Phase 4
Start date March 25, 2024
Completion date July 31, 2025

See also
  Status Clinical Trial Phase
Not yet recruiting NCT05483569 - Diaphragmatic Exercises and Fascial Release Techniques on the Treatment of Lower Extremity Lymphedema N/A
Completed NCT04360889 - Lipid Peroxidation and Options Antioxidant Therapy for Secondary Lymphedema of the Lower Extremities Phase 4
Completed NCT01914276 - Lymphedema in Endometrial Cancer N/A
Not yet recruiting NCT06251856 - Feasibility and Effectiveness of Lymphedema Education Program After Gynecological Cancer Surgery N/A
Completed NCT03080207 - Platelet Rich Plasma, Complex Decongestive Physiotherapy and Low Level Laser in Treatment of Lower Extremity Lymphoedema N/A